Extracorporeal Photopheresis : Cellular Photoimmunotherapy /

Mostrar otras versiones (1)

Extracorporeal photopheresis (ECP) is the first FDA approved cellular photoimmunotherapy for cancer and has demonstrated efficacy in T-cell mediated disorders including prevention and treatment of acute and chronic graft-versus-host disease, organ transplant rejection, scleroderma, Crohn's dise...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Greinix, Hildegard T., Knobler, Robert
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin : De Gruyter, ©2012.
Temas:
Photochemotherapy.
Cancer > Treatment.
Graft vs Host Disease > therapy
Immunotherapy > methods
Lymphoma, T-Cell, Cutaneous > therapy
Photopheresis > methods
Photochemotherapy
Photochimiothérapie.
Cancer > Traitement.
HEALTH & FITNESS > Diseases > Cancer.
MEDICAL > Oncology.
Cancer > Treatment
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Frontmatter
  • Preface
  • Content
  • Authors Index
  • Section 1: History of Extracorporeal Photopheresis
  • Section 2: Technical Aspects
  • Section 3: Mechanisms of Action of ECP
  • Section 4: Extracorporeal Photopheresis in Acute Graft-versus-Host Disease
  • Section 5: Extracorporeal Photopheresis in Chronic Graft-versus-Host Disease
  • Section 6: ECP for the Prevention of Graft-versus-Host Disease
  • Section 7: ECP in Cutaneous T Cell Lymphoma
  • Section 8: ECP in Scleroderma and Other Skin Diseases
  • Section 9: ECP in Crohn's Disease
  • Section 10: Extracorporeal Photopheresis after Solid Organ/Tissue Transplantation
  • Section 11: ECP in Diabetes Mellitus
  • Section 12: Side Effects of Extracorporeal Photopheresis
  • Section 13: Summary.

Ejemplares similares